nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethacrynic acid—GSTA2—prostate cancer	0.528	1	CbGaD
Ethacrynic acid—ALB—Abiraterone—prostate cancer	0.0716	0.328	CbGbCtD
Ethacrynic acid—ALB—Estrone—prostate cancer	0.0518	0.237	CbGbCtD
Ethacrynic acid—SLC22A6—Conjugated Estrogens—prostate cancer	0.0398	0.182	CbGbCtD
Ethacrynic acid—ALB—Estradiol—prostate cancer	0.0297	0.136	CbGbCtD
Ethacrynic acid—ALB—Prednisone—prostate cancer	0.0256	0.117	CbGbCtD
Ethacrynic acid—GSTA2—urine—prostate cancer	0.00909	0.191	CbGeAlD
Ethacrynic acid—SLC12A1—urine—prostate cancer	0.00826	0.174	CbGeAlD
Ethacrynic acid—GSTA2—prostate gland—prostate cancer	0.00326	0.0687	CbGeAlD
Ethacrynic acid—SLC12A1—prostate gland—prostate cancer	0.00297	0.0625	CbGeAlD
Ethacrynic acid—GSTA2—epithelium—prostate cancer	0.0024	0.0505	CbGeAlD
Ethacrynic acid—GSTA2—renal system—prostate cancer	0.00222	0.0468	CbGeAlD
Ethacrynic acid—SLC12A1—epithelium—prostate cancer	0.00218	0.0459	CbGeAlD
Ethacrynic acid—SLC12A1—renal system—prostate cancer	0.00202	0.0426	CbGeAlD
Ethacrynic acid—SLC12A1—urethra—prostate cancer	0.00199	0.0418	CbGeAlD
Ethacrynic acid—ATP1A1—prostate gland—prostate cancer	0.00173	0.0364	CbGeAlD
Ethacrynic acid—ATP1A1—seminal vesicle—prostate cancer	0.00146	0.0308	CbGeAlD
Ethacrynic acid—GSTA2—testis—prostate cancer	0.00144	0.0303	CbGeAlD
Ethacrynic acid—SLC12A1—testis—prostate cancer	0.00131	0.0275	CbGeAlD
Ethacrynic acid—ATP1A1—epithelium—prostate cancer	0.00127	0.0267	CbGeAlD
Ethacrynic acid—ATP1A1—renal system—prostate cancer	0.00118	0.0248	CbGeAlD
Ethacrynic acid—ATP1A1—urethra—prostate cancer	0.00116	0.0243	CbGeAlD
Ethacrynic acid—ATP1A1—bone marrow—prostate cancer	0.00089	0.0187	CbGeAlD
Ethacrynic acid—ALB—testis—prostate cancer	0.00079	0.0166	CbGeAlD
Ethacrynic acid—ATP1A1—testis—prostate cancer	0.000761	0.016	CbGeAlD
Ethacrynic acid—ALB—lymph node—prostate cancer	0.000573	0.0121	CbGeAlD
Ethacrynic acid—ATP1A1—lymph node—prostate cancer	0.000551	0.0116	CbGeAlD
Ethacrynic acid—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000247	0.00215	CcSEcCtD
Ethacrynic acid—Chills—Estradiol—prostate cancer	0.000247	0.00214	CcSEcCtD
Ethacrynic acid—Nausea—Cabazitaxel—prostate cancer	0.000245	0.00213	CcSEcCtD
Ethacrynic acid—Diarrhoea—Bicalutamide—prostate cancer	0.000242	0.00211	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Epirubicin—prostate cancer	0.000242	0.00211	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Goserelin—prostate cancer	0.000241	0.0021	CcSEcCtD
Ethacrynic acid—Hyperuricaemia—Doxorubicin—prostate cancer	0.000237	0.00206	CcSEcCtD
Ethacrynic acid—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000237	0.00206	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Docetaxel—prostate cancer	0.000236	0.00205	CcSEcCtD
Ethacrynic acid—Anorexia—Goserelin—prostate cancer	0.000235	0.00204	CcSEcCtD
Ethacrynic acid—Anorexia—Conjugated Estrogens—prostate cancer	0.000233	0.00202	CcSEcCtD
Ethacrynic acid—Jaundice—Etoposide—prostate cancer	0.000232	0.00201	CcSEcCtD
Ethacrynic acid—Chills—Mitoxantrone—prostate cancer	0.00023	0.002	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Capecitabine—prostate cancer	0.000229	0.00199	CcSEcCtD
Ethacrynic acid—Vomiting—Bicalutamide—prostate cancer	0.000225	0.00196	CcSEcCtD
Ethacrynic acid—Blood uric acid increased—Doxorubicin—prostate cancer	0.000224	0.00195	CcSEcCtD
Ethacrynic acid—Rash—Bicalutamide—prostate cancer	0.000223	0.00194	CcSEcCtD
Ethacrynic acid—Dermatitis—Bicalutamide—prostate cancer	0.000223	0.00194	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Estradiol—prostate cancer	0.000222	0.00193	CcSEcCtD
Ethacrynic acid—Headache—Bicalutamide—prostate cancer	0.000222	0.00193	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Etoposide—prostate cancer	0.000222	0.00193	CcSEcCtD
Ethacrynic acid—Dysphagia—Docetaxel—prostate cancer	0.000221	0.00192	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000221	0.00192	CcSEcCtD
Ethacrynic acid—Malaise—Estradiol—prostate cancer	0.000216	0.00188	CcSEcCtD
Ethacrynic acid—Vertigo—Estradiol—prostate cancer	0.000215	0.00187	CcSEcCtD
Ethacrynic acid—Asthenia—Ethinyl Estradiol—prostate cancer	0.000215	0.00187	CcSEcCtD
Ethacrynic acid—Dysphagia—Capecitabine—prostate cancer	0.000214	0.00186	CcSEcCtD
Ethacrynic acid—Decreased appetite—Goserelin—prostate cancer	0.000214	0.00186	CcSEcCtD
Ethacrynic acid—Fatigue—Goserelin—prostate cancer	0.000213	0.00185	CcSEcCtD
Ethacrynic acid—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000212	0.00184	CcSEcCtD
Ethacrynic acid—Pain—Goserelin—prostate cancer	0.000211	0.00183	CcSEcCtD
Ethacrynic acid—Fatigue—Conjugated Estrogens—prostate cancer	0.000211	0.00183	CcSEcCtD
Ethacrynic acid—Nausea—Bicalutamide—prostate cancer	0.000211	0.00183	CcSEcCtD
Ethacrynic acid—Vision blurred—Mitoxantrone—prostate cancer	0.00021	0.00183	CcSEcCtD
Ethacrynic acid—Pain—Conjugated Estrogens—prostate cancer	0.000209	0.00181	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000207	0.0018	CcSEcCtD
Ethacrynic acid—Neutropenia—Docetaxel—prostate cancer	0.000207	0.0018	CcSEcCtD
Ethacrynic acid—Abdominal discomfort—Capecitabine—prostate cancer	0.000205	0.00179	CcSEcCtD
Ethacrynic acid—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000205	0.00178	CcSEcCtD
Ethacrynic acid—Anxiety—Estradiol—prostate cancer	0.000203	0.00177	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Goserelin—prostate cancer	0.000203	0.00177	CcSEcCtD
Ethacrynic acid—Discomfort—Estradiol—prostate cancer	0.000201	0.00175	CcSEcCtD
Ethacrynic acid—Malaise—Mitoxantrone—prostate cancer	0.000201	0.00175	CcSEcCtD
Ethacrynic acid—Neutropenia—Capecitabine—prostate cancer	0.0002	0.00174	CcSEcCtD
Ethacrynic acid—Confusional state—Estradiol—prostate cancer	0.000197	0.00171	CcSEcCtD
Ethacrynic acid—Body temperature increased—Goserelin—prostate cancer	0.000195	0.00169	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Capecitabine—prostate cancer	0.000193	0.00168	CcSEcCtD
Ethacrynic acid—Convulsion—Mitoxantrone—prostate cancer	0.000193	0.00168	CcSEcCtD
Ethacrynic acid—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000193	0.00168	CcSEcCtD
Ethacrynic acid—Jaundice—Docetaxel—prostate cancer	0.000192	0.00167	CcSEcCtD
Ethacrynic acid—Chills—Etoposide—prostate cancer	0.000191	0.00166	CcSEcCtD
Ethacrynic acid—Vomiting—Ethinyl Estradiol—prostate cancer	0.00019	0.00166	CcSEcCtD
Ethacrynic acid—Anxiety—Mitoxantrone—prostate cancer	0.000189	0.00165	CcSEcCtD
Ethacrynic acid—Rash—Ethinyl Estradiol—prostate cancer	0.000189	0.00164	CcSEcCtD
Ethacrynic acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000189	0.00164	CcSEcCtD
Ethacrynic acid—Discomfort—Mitoxantrone—prostate cancer	0.000188	0.00163	CcSEcCtD
Ethacrynic acid—Headache—Ethinyl Estradiol—prostate cancer	0.000188	0.00163	CcSEcCtD
Ethacrynic acid—Jaundice—Capecitabine—prostate cancer	0.000186	0.00162	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Docetaxel—prostate cancer	0.000184	0.0016	CcSEcCtD
Ethacrynic acid—Confusional state—Mitoxantrone—prostate cancer	0.000184	0.0016	CcSEcCtD
Ethacrynic acid—Haematuria—Capecitabine—prostate cancer	0.000182	0.00158	CcSEcCtD
Ethacrynic acid—Neutropenia—Prednisone—prostate cancer	0.000179	0.00155	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Capecitabine—prostate cancer	0.000178	0.00155	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000178	0.00155	CcSEcCtD
Ethacrynic acid—Nausea—Ethinyl Estradiol—prostate cancer	0.000178	0.00155	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Epirubicin—prostate cancer	0.000177	0.00154	CcSEcCtD
Ethacrynic acid—Asthenia—Goserelin—prostate cancer	0.000177	0.00154	CcSEcCtD
Ethacrynic acid—Asthenia—Conjugated Estrogens—prostate cancer	0.000175	0.00152	CcSEcCtD
Ethacrynic acid—Anorexia—Mitoxantrone—prostate cancer	0.000174	0.00151	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000173	0.0015	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Prednisone—prostate cancer	0.000172	0.0015	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Etoposide—prostate cancer	0.000172	0.0015	CcSEcCtD
Ethacrynic acid—Decreased appetite—Estradiol—prostate cancer	0.00017	0.00148	CcSEcCtD
Ethacrynic acid—Diarrhoea—Goserelin—prostate cancer	0.000169	0.00147	CcSEcCtD
Ethacrynic acid—Fatigue—Estradiol—prostate cancer	0.000169	0.00146	CcSEcCtD
Ethacrynic acid—Malaise—Etoposide—prostate cancer	0.000167	0.00145	CcSEcCtD
Ethacrynic acid—Pain—Estradiol—prostate cancer	0.000167	0.00145	CcSEcCtD
Ethacrynic acid—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000167	0.00145	CcSEcCtD
Ethacrynic acid—Vertigo—Etoposide—prostate cancer	0.000167	0.00145	CcSEcCtD
Ethacrynic acid—Hypoglycaemia—Doxorubicin—prostate cancer	0.000164	0.00142	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Estradiol—prostate cancer	0.000161	0.0014	CcSEcCtD
Ethacrynic acid—Convulsion—Etoposide—prostate cancer	0.000161	0.0014	CcSEcCtD
Ethacrynic acid—Tinnitus—Capecitabine—prostate cancer	0.00016	0.00139	CcSEcCtD
Ethacrynic acid—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.00016	0.00139	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Epirubicin—prostate cancer	0.000159	0.00139	CcSEcCtD
Ethacrynic acid—Chills—Docetaxel—prostate cancer	0.000159	0.00138	CcSEcCtD
Ethacrynic acid—Decreased appetite—Mitoxantrone—prostate cancer	0.000158	0.00138	CcSEcCtD
Ethacrynic acid—Fatigue—Mitoxantrone—prostate cancer	0.000157	0.00136	CcSEcCtD
Ethacrynic acid—Vomiting—Goserelin—prostate cancer	0.000157	0.00136	CcSEcCtD
Ethacrynic acid—Discomfort—Etoposide—prostate cancer	0.000156	0.00136	CcSEcCtD
Ethacrynic acid—Pain—Mitoxantrone—prostate cancer	0.000156	0.00135	CcSEcCtD
Ethacrynic acid—Rash—Goserelin—prostate cancer	0.000155	0.00135	CcSEcCtD
Ethacrynic acid—Dermatitis—Goserelin—prostate cancer	0.000155	0.00135	CcSEcCtD
Ethacrynic acid—Vomiting—Conjugated Estrogens—prostate cancer	0.000155	0.00135	CcSEcCtD
Ethacrynic acid—Body temperature increased—Estradiol—prostate cancer	0.000155	0.00134	CcSEcCtD
Ethacrynic acid—Headache—Goserelin—prostate cancer	0.000154	0.00134	CcSEcCtD
Ethacrynic acid—Rash—Conjugated Estrogens—prostate cancer	0.000154	0.00134	CcSEcCtD
Ethacrynic acid—Chills—Capecitabine—prostate cancer	0.000154	0.00134	CcSEcCtD
Ethacrynic acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000154	0.00134	CcSEcCtD
Ethacrynic acid—Headache—Conjugated Estrogens—prostate cancer	0.000153	0.00133	CcSEcCtD
Ethacrynic acid—Confusional state—Etoposide—prostate cancer	0.000153	0.00133	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Mitoxantrone—prostate cancer	0.00015	0.0013	CcSEcCtD
Ethacrynic acid—Dysphagia—Epirubicin—prostate cancer	0.000149	0.0013	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Etoposide—prostate cancer	0.000148	0.00129	CcSEcCtD
Ethacrynic acid—Liver function test abnormal—Doxorubicin—prostate cancer	0.000148	0.00128	CcSEcCtD
Ethacrynic acid—Nausea—Goserelin—prostate cancer	0.000146	0.00127	CcSEcCtD
Ethacrynic acid—Nausea—Conjugated Estrogens—prostate cancer	0.000145	0.00126	CcSEcCtD
Ethacrynic acid—Anorexia—Etoposide—prostate cancer	0.000144	0.00125	CcSEcCtD
Ethacrynic acid—Body temperature increased—Mitoxantrone—prostate cancer	0.000144	0.00125	CcSEcCtD
Ethacrynic acid—Vision blurred—Capecitabine—prostate cancer	0.000141	0.00122	CcSEcCtD
Ethacrynic acid—Asthenia—Estradiol—prostate cancer	0.00014	0.00122	CcSEcCtD
Ethacrynic acid—Neutropenia—Epirubicin—prostate cancer	0.00014	0.00121	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Capecitabine—prostate cancer	0.000139	0.0012	CcSEcCtD
Ethacrynic acid—Dysphagia—Doxorubicin—prostate cancer	0.000138	0.0012	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Epirubicin—prostate cancer	0.000135	0.00117	CcSEcCtD
Ethacrynic acid—Malaise—Capecitabine—prostate cancer	0.000135	0.00117	CcSEcCtD
Ethacrynic acid—Vertigo—Capecitabine—prostate cancer	0.000134	0.00117	CcSEcCtD
Ethacrynic acid—Diarrhoea—Estradiol—prostate cancer	0.000134	0.00116	CcSEcCtD
Ethacrynic acid—Convulsion—Docetaxel—prostate cancer	0.000134	0.00116	CcSEcCtD
Ethacrynic acid—Decreased appetite—Etoposide—prostate cancer	0.000132	0.00114	CcSEcCtD
Ethacrynic acid—Asthenia—Mitoxantrone—prostate cancer	0.000131	0.00114	CcSEcCtD
Ethacrynic acid—Fatigue—Etoposide—prostate cancer	0.000131	0.00113	CcSEcCtD
Ethacrynic acid—Jaundice—Epirubicin—prostate cancer	0.00013	0.00113	CcSEcCtD
Ethacrynic acid—Pain—Etoposide—prostate cancer	0.00013	0.00113	CcSEcCtD
Ethacrynic acid—Neutropenia—Doxorubicin—prostate cancer	0.000129	0.00112	CcSEcCtD
Ethacrynic acid—Haematuria—Epirubicin—prostate cancer	0.000127	0.0011	CcSEcCtD
Ethacrynic acid—Confusional state—Docetaxel—prostate cancer	0.000127	0.0011	CcSEcCtD
Ethacrynic acid—Anxiety—Capecitabine—prostate cancer	0.000127	0.0011	CcSEcCtD
Ethacrynic acid—Discomfort—Capecitabine—prostate cancer	0.000126	0.00109	CcSEcCtD
Ethacrynic acid—Vision blurred—Prednisone—prostate cancer	0.000125	0.00109	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Etoposide—prostate cancer	0.000125	0.00108	CcSEcCtD
Ethacrynic acid—Hyperglycaemia—Doxorubicin—prostate cancer	0.000125	0.00108	CcSEcCtD
Ethacrynic acid—Diarrhoea—Mitoxantrone—prostate cancer	0.000125	0.00108	CcSEcCtD
Ethacrynic acid—Vomiting—Estradiol—prostate cancer	0.000124	0.00108	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Epirubicin—prostate cancer	0.000124	0.00108	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Prednisone—prostate cancer	0.000123	0.00107	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Docetaxel—prostate cancer	0.000123	0.00107	CcSEcCtD
Ethacrynic acid—Rash—Estradiol—prostate cancer	0.000123	0.00107	CcSEcCtD
Ethacrynic acid—Dermatitis—Estradiol—prostate cancer	0.000123	0.00107	CcSEcCtD
Ethacrynic acid—Confusional state—Capecitabine—prostate cancer	0.000123	0.00107	CcSEcCtD
Ethacrynic acid—Headache—Estradiol—prostate cancer	0.000122	0.00106	CcSEcCtD
Ethacrynic acid—Jaundice—Doxorubicin—prostate cancer	0.00012	0.00104	CcSEcCtD
Ethacrynic acid—Anorexia—Docetaxel—prostate cancer	0.00012	0.00104	CcSEcCtD
Ethacrynic acid—Malaise—Prednisone—prostate cancer	0.00012	0.00104	CcSEcCtD
Ethacrynic acid—Body temperature increased—Etoposide—prostate cancer	0.00012	0.00104	CcSEcCtD
Ethacrynic acid—Vertigo—Prednisone—prostate cancer	0.00012	0.00104	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Capecitabine—prostate cancer	0.000119	0.00104	CcSEcCtD
Ethacrynic acid—Haematuria—Doxorubicin—prostate cancer	0.000117	0.00102	CcSEcCtD
Ethacrynic acid—Anorexia—Capecitabine—prostate cancer	0.000116	0.00101	CcSEcCtD
Ethacrynic acid—Nausea—Estradiol—prostate cancer	0.000116	0.00101	CcSEcCtD
Ethacrynic acid—Vomiting—Mitoxantrone—prostate cancer	0.000116	0.00101	CcSEcCtD
Ethacrynic acid—Convulsion—Prednisone—prostate cancer	0.000115	0.001	CcSEcCtD
Ethacrynic acid—Agranulocytosis—Doxorubicin—prostate cancer	0.000115	0.000999	CcSEcCtD
Ethacrynic acid—Rash—Mitoxantrone—prostate cancer	0.000115	0.000998	CcSEcCtD
Ethacrynic acid—Dermatitis—Mitoxantrone—prostate cancer	0.000115	0.000997	CcSEcCtD
Ethacrynic acid—Headache—Mitoxantrone—prostate cancer	0.000114	0.000991	CcSEcCtD
Ethacrynic acid—Anxiety—Prednisone—prostate cancer	0.000113	0.000981	CcSEcCtD
Ethacrynic acid—Discomfort—Prednisone—prostate cancer	0.000112	0.000972	CcSEcCtD
Ethacrynic acid—Tinnitus—Epirubicin—prostate cancer	0.000111	0.000968	CcSEcCtD
Ethacrynic acid—Decreased appetite—Docetaxel—prostate cancer	0.000109	0.000951	CcSEcCtD
Ethacrynic acid—Asthenia—Etoposide—prostate cancer	0.000109	0.000944	CcSEcCtD
Ethacrynic acid—Fatigue—Docetaxel—prostate cancer	0.000109	0.000943	CcSEcCtD
Ethacrynic acid—Nausea—Mitoxantrone—prostate cancer	0.000108	0.00094	CcSEcCtD
Ethacrynic acid—Pain—Docetaxel—prostate cancer	0.000108	0.000935	CcSEcCtD
Ethacrynic acid—Chills—Epirubicin—prostate cancer	0.000107	0.000932	CcSEcCtD
Ethacrynic acid—Decreased appetite—Capecitabine—prostate cancer	0.000106	0.000921	CcSEcCtD
Ethacrynic acid—Fatigue—Capecitabine—prostate cancer	0.000105	0.000913	CcSEcCtD
Ethacrynic acid—Pain—Capecitabine—prostate cancer	0.000104	0.000906	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Docetaxel—prostate cancer	0.000104	0.000901	CcSEcCtD
Ethacrynic acid—Diarrhoea—Etoposide—prostate cancer	0.000104	0.000901	CcSEcCtD
Ethacrynic acid—Anorexia—Prednisone—prostate cancer	0.000103	0.000899	CcSEcCtD
Ethacrynic acid—Tinnitus—Doxorubicin—prostate cancer	0.000103	0.000896	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Capecitabine—prostate cancer	0.0001	0.000873	CcSEcCtD
Ethacrynic acid—Body temperature increased—Docetaxel—prostate cancer	9.95e-05	0.000865	CcSEcCtD
Ethacrynic acid—Chills—Doxorubicin—prostate cancer	9.92e-05	0.000862	CcSEcCtD
Ethacrynic acid—Vision blurred—Epirubicin—prostate cancer	9.8e-05	0.000852	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Epirubicin—prostate cancer	9.65e-05	0.000839	CcSEcCtD
Ethacrynic acid—Body temperature increased—Capecitabine—prostate cancer	9.63e-05	0.000837	CcSEcCtD
Ethacrynic acid—Vomiting—Etoposide—prostate cancer	9.63e-05	0.000837	CcSEcCtD
Ethacrynic acid—Rash—Etoposide—prostate cancer	9.55e-05	0.00083	CcSEcCtD
Ethacrynic acid—Dermatitis—Etoposide—prostate cancer	9.54e-05	0.000829	CcSEcCtD
Ethacrynic acid—Headache—Etoposide—prostate cancer	9.49e-05	0.000825	CcSEcCtD
Ethacrynic acid—Decreased appetite—Prednisone—prostate cancer	9.44e-05	0.00082	CcSEcCtD
Ethacrynic acid—Malaise—Epirubicin—prostate cancer	9.38e-05	0.000815	CcSEcCtD
Ethacrynic acid—Fatigue—Prednisone—prostate cancer	9.36e-05	0.000813	CcSEcCtD
Ethacrynic acid—Vertigo—Epirubicin—prostate cancer	9.35e-05	0.000812	CcSEcCtD
Ethacrynic acid—Vision blurred—Doxorubicin—prostate cancer	9.07e-05	0.000788	CcSEcCtD
Ethacrynic acid—Asthenia—Docetaxel—prostate cancer	9.03e-05	0.000785	CcSEcCtD
Ethacrynic acid—Convulsion—Epirubicin—prostate cancer	9.01e-05	0.000783	CcSEcCtD
Ethacrynic acid—Nausea—Etoposide—prostate cancer	9e-05	0.000782	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Prednisone—prostate cancer	8.95e-05	0.000777	CcSEcCtD
Ethacrynic acid—Ill-defined disorder—Doxorubicin—prostate cancer	8.93e-05	0.000776	CcSEcCtD
Ethacrynic acid—Anxiety—Epirubicin—prostate cancer	8.83e-05	0.000767	CcSEcCtD
Ethacrynic acid—Discomfort—Epirubicin—prostate cancer	8.75e-05	0.00076	CcSEcCtD
Ethacrynic acid—Asthenia—Capecitabine—prostate cancer	8.74e-05	0.00076	CcSEcCtD
Ethacrynic acid—Malaise—Doxorubicin—prostate cancer	8.68e-05	0.000754	CcSEcCtD
Ethacrynic acid—Vertigo—Doxorubicin—prostate cancer	8.65e-05	0.000752	CcSEcCtD
Ethacrynic acid—Diarrhoea—Docetaxel—prostate cancer	8.61e-05	0.000748	CcSEcCtD
Ethacrynic acid—Body temperature increased—Prednisone—prostate cancer	8.58e-05	0.000746	CcSEcCtD
Ethacrynic acid—Confusional state—Epirubicin—prostate cancer	8.56e-05	0.000744	CcSEcCtD
Ethacrynic acid—Convulsion—Doxorubicin—prostate cancer	8.34e-05	0.000725	CcSEcCtD
Ethacrynic acid—Diarrhoea—Capecitabine—prostate cancer	8.34e-05	0.000725	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Epirubicin—prostate cancer	8.31e-05	0.000722	CcSEcCtD
Ethacrynic acid—Anxiety—Doxorubicin—prostate cancer	8.17e-05	0.00071	CcSEcCtD
Ethacrynic acid—Discomfort—Doxorubicin—prostate cancer	8.1e-05	0.000704	CcSEcCtD
Ethacrynic acid—Anorexia—Epirubicin—prostate cancer	8.09e-05	0.000703	CcSEcCtD
Ethacrynic acid—Vomiting—Docetaxel—prostate cancer	8e-05	0.000696	CcSEcCtD
Ethacrynic acid—Rash—Docetaxel—prostate cancer	7.94e-05	0.00069	CcSEcCtD
Ethacrynic acid—Dermatitis—Docetaxel—prostate cancer	7.93e-05	0.000689	CcSEcCtD
Ethacrynic acid—Confusional state—Doxorubicin—prostate cancer	7.92e-05	0.000688	CcSEcCtD
Ethacrynic acid—Headache—Docetaxel—prostate cancer	7.89e-05	0.000685	CcSEcCtD
Ethacrynic acid—Asthenia—Prednisone—prostate cancer	7.79e-05	0.000677	CcSEcCtD
Ethacrynic acid—Vomiting—Capecitabine—prostate cancer	7.75e-05	0.000673	CcSEcCtD
Ethacrynic acid—Thrombocytopenia—Doxorubicin—prostate cancer	7.69e-05	0.000668	CcSEcCtD
Ethacrynic acid—Rash—Capecitabine—prostate cancer	7.68e-05	0.000668	CcSEcCtD
Ethacrynic acid—Dermatitis—Capecitabine—prostate cancer	7.68e-05	0.000667	CcSEcCtD
Ethacrynic acid—Headache—Capecitabine—prostate cancer	7.64e-05	0.000663	CcSEcCtD
Ethacrynic acid—Anorexia—Doxorubicin—prostate cancer	7.49e-05	0.000651	CcSEcCtD
Ethacrynic acid—Nausea—Docetaxel—prostate cancer	7.48e-05	0.00065	CcSEcCtD
Ethacrynic acid—Diarrhoea—Prednisone—prostate cancer	7.43e-05	0.000645	CcSEcCtD
Ethacrynic acid—Decreased appetite—Epirubicin—prostate cancer	7.38e-05	0.000641	CcSEcCtD
Ethacrynic acid—Fatigue—Epirubicin—prostate cancer	7.32e-05	0.000636	CcSEcCtD
Ethacrynic acid—Pain—Epirubicin—prostate cancer	7.26e-05	0.000631	CcSEcCtD
Ethacrynic acid—Nausea—Capecitabine—prostate cancer	7.24e-05	0.000629	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Epirubicin—prostate cancer	7e-05	0.000608	CcSEcCtD
Ethacrynic acid—Vomiting—Prednisone—prostate cancer	6.9e-05	0.0006	CcSEcCtD
Ethacrynic acid—Rash—Prednisone—prostate cancer	6.85e-05	0.000595	CcSEcCtD
Ethacrynic acid—Dermatitis—Prednisone—prostate cancer	6.84e-05	0.000594	CcSEcCtD
Ethacrynic acid—Decreased appetite—Doxorubicin—prostate cancer	6.83e-05	0.000593	CcSEcCtD
Ethacrynic acid—Headache—Prednisone—prostate cancer	6.8e-05	0.000591	CcSEcCtD
Ethacrynic acid—Fatigue—Doxorubicin—prostate cancer	6.77e-05	0.000589	CcSEcCtD
Ethacrynic acid—Pain—Doxorubicin—prostate cancer	6.72e-05	0.000584	CcSEcCtD
Ethacrynic acid—Body temperature increased—Epirubicin—prostate cancer	6.71e-05	0.000583	CcSEcCtD
Ethacrynic acid—Feeling abnormal—Doxorubicin—prostate cancer	6.47e-05	0.000563	CcSEcCtD
Ethacrynic acid—Nausea—Prednisone—prostate cancer	6.45e-05	0.00056	CcSEcCtD
Ethacrynic acid—Body temperature increased—Doxorubicin—prostate cancer	6.21e-05	0.00054	CcSEcCtD
Ethacrynic acid—Asthenia—Epirubicin—prostate cancer	6.09e-05	0.000529	CcSEcCtD
Ethacrynic acid—Diarrhoea—Epirubicin—prostate cancer	5.81e-05	0.000505	CcSEcCtD
Ethacrynic acid—Asthenia—Doxorubicin—prostate cancer	5.64e-05	0.00049	CcSEcCtD
Ethacrynic acid—Vomiting—Epirubicin—prostate cancer	5.4e-05	0.000469	CcSEcCtD
Ethacrynic acid—Diarrhoea—Doxorubicin—prostate cancer	5.38e-05	0.000467	CcSEcCtD
Ethacrynic acid—Rash—Epirubicin—prostate cancer	5.35e-05	0.000465	CcSEcCtD
Ethacrynic acid—Dermatitis—Epirubicin—prostate cancer	5.35e-05	0.000465	CcSEcCtD
Ethacrynic acid—Headache—Epirubicin—prostate cancer	5.32e-05	0.000462	CcSEcCtD
Ethacrynic acid—Nausea—Epirubicin—prostate cancer	5.04e-05	0.000438	CcSEcCtD
Ethacrynic acid—Vomiting—Doxorubicin—prostate cancer	5e-05	0.000434	CcSEcCtD
Ethacrynic acid—Rash—Doxorubicin—prostate cancer	4.95e-05	0.00043	CcSEcCtD
Ethacrynic acid—Dermatitis—Doxorubicin—prostate cancer	4.95e-05	0.00043	CcSEcCtD
Ethacrynic acid—Headache—Doxorubicin—prostate cancer	4.92e-05	0.000428	CcSEcCtD
Ethacrynic acid—Nausea—Doxorubicin—prostate cancer	4.67e-05	0.000406	CcSEcCtD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CYP7B1—prostate cancer	2.94e-05	0.000326	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP2E1—prostate cancer	2.91e-05	0.000323	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NQO1—prostate cancer	2.88e-05	0.000319	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	2.88e-05	0.000319	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	2.88e-05	0.000319	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC26A4—prostate cancer	2.87e-05	0.000318	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC12A2—prostate cancer	2.87e-05	0.000318	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TH—prostate cancer	2.84e-05	0.000314	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGA6—prostate cancer	2.82e-05	0.000312	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP3A4—prostate cancer	2.81e-05	0.000311	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.79e-05	0.000309	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	2.76e-05	0.000306	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1B1—prostate cancer	2.76e-05	0.000306	CbGpPWpGaD
Ethacrynic acid—ALB—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	2.72e-05	0.000302	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—PTGS2—prostate cancer	2.7e-05	0.0003	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GGT1—prostate cancer	2.67e-05	0.000296	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.66e-05	0.000295	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CD9—prostate cancer	2.65e-05	0.000293	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NCOA1—prostate cancer	2.63e-05	0.000292	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HAO1—prostate cancer	2.62e-05	0.000291	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP19A1—prostate cancer	2.59e-05	0.000288	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	2.53e-05	0.000281	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—RXRA—prostate cancer	2.5e-05	0.000277	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	2.46e-05	0.000272	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.45e-05	0.000271	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—COMT—prostate cancer	2.41e-05	0.000267	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTP1—prostate cancer	2.4e-05	0.000266	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CLU—prostate cancer	2.4e-05	0.000265	CbGpPWpGaD
Ethacrynic acid—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	2.37e-05	0.000262	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ITPR1—prostate cancer	2.36e-05	0.000262	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.35e-05	0.000261	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.35e-05	0.00026	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.33e-05	0.000258	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—VEGFA—prostate cancer	2.3e-05	0.000255	CbGpPWpGaD
Ethacrynic acid—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	2.28e-05	0.000252	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.26e-05	0.00025	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	2.24e-05	0.000248	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—TYMS—prostate cancer	2.23e-05	0.000247	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—GSTM1—prostate cancer	2.21e-05	0.000244	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GRB7—prostate cancer	2.19e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	2.19e-05	0.000243	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.18e-05	0.000242	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	2.18e-05	0.000241	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—LPL—prostate cancer	2.17e-05	0.00024	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.15e-05	0.000238	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CSAD—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CBR1—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TST—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PSAT1—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ADI1—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GRHL1—prostate cancer	2.14e-05	0.000237	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet degranulation—TGFB1—prostate cancer	2.11e-05	0.000234	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CYP1A1—prostate cancer	2.09e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.09e-05	0.000232	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—GNG5—prostate cancer	2.08e-05	0.000231	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—ERCC2—prostate cancer	2.07e-05	0.00023	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.05e-05	0.000227	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—TP53—prostate cancer	2.02e-05	0.000224	CbGpPWpGaD
Ethacrynic acid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	2.01e-05	0.000223	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGT2B17—prostate cancer	1.99e-05	0.00022	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UGT2B15—prostate cancer	1.99e-05	0.00022	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GRHPR—prostate cancer	1.99e-05	0.00022	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CKMT2—prostate cancer	1.99e-05	0.00022	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—MTHFR—prostate cancer	1.95e-05	0.000216	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.94e-05	0.000215	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PPARA—prostate cancer	1.91e-05	0.000212	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.91e-05	0.000212	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.9e-05	0.00021	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SULT2B1—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MBTPS1—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PGAM2—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM3—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—RFK—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAGLU—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AOX1—prostate cancer	1.87e-05	0.000207	CbGpPWpGaD
Ethacrynic acid—ALB—Folate Metabolism—IL6—prostate cancer	1.85e-05	0.000205	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.83e-05	0.000202	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	1.8e-05	0.0002	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CAV1—prostate cancer	1.8e-05	0.000199	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKACB—prostate cancer	1.78e-05	0.000197	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP3A43—prostate cancer	1.77e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—DEGS1—prostate cancer	1.77e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT1—prostate cancer	1.77e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SRD5A2—prostate cancer	1.77e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AMACR—prostate cancer	1.77e-05	0.000196	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.74e-05	0.000193	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.73e-05	0.000192	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—THBS1—prostate cancer	1.73e-05	0.000192	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.71e-05	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	1.7e-05	0.000189	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD17B1—prostate cancer	1.69e-05	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.69e-05	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	1.68e-05	0.000187	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCZ—prostate cancer	1.68e-05	0.000186	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CG—prostate cancer	1.64e-05	0.000182	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.63e-05	0.00018	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.62e-05	0.000179	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.6e-05	0.000177	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	1.56e-05	0.000173	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—INS—prostate cancer	1.55e-05	0.000172	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.54e-05	0.00017	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.53e-05	0.000169	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—CREBBP—prostate cancer	1.52e-05	0.000168	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGD—prostate cancer	1.51e-05	0.000167	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—B4GALT4—prostate cancer	1.51e-05	0.000167	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	1.5e-05	0.000166	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	1.48e-05	0.000164	CbGpPWpGaD
Ethacrynic acid—ALB—Selenium Micronutrient Network—IL6—prostate cancer	1.47e-05	0.000163	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.45e-05	0.000161	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CD—prostate cancer	1.44e-05	0.00016	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PRKCQ—prostate cancer	1.42e-05	0.000158	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TNFRSF21—prostate cancer	1.42e-05	0.000157	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAUR—prostate cancer	1.41e-05	0.000156	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.38e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP7B1—prostate cancer	1.38e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTAP—prostate cancer	1.38e-05	0.000153	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	1.37e-05	0.000152	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—NOS3—prostate cancer	1.36e-05	0.000151	CbGpPWpGaD
Ethacrynic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.36e-05	0.00015	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.35e-05	0.000149	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SULT1E1—prostate cancer	1.34e-05	0.000149	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SRD5A1—prostate cancer	1.34e-05	0.000149	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VAV3—prostate cancer	1.31e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	1.31e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.3e-05	0.000145	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.29e-05	0.000142	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACSL4—prostate cancer	1.28e-05	0.000142	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD17B3—prostate cancer	1.28e-05	0.000142	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITPR1—prostate cancer	1.27e-05	0.00014	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.27e-05	0.00014	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CB—prostate cancer	1.26e-05	0.000139	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTGS2—prostate cancer	1.24e-05	0.000138	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UMPS—prostate cancer	1.23e-05	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ARG2—prostate cancer	1.23e-05	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PHGDH—prostate cancer	1.23e-05	0.000136	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.22e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.22e-05	0.000135	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LDHB—prostate cancer	1.2e-05	0.000134	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	1.2e-05	0.000133	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP3A5—prostate cancer	1.18e-05	0.000131	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	1.16e-05	0.000129	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PDHA1—prostate cancer	1.14e-05	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TCN2—prostate cancer	1.14e-05	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA3—prostate cancer	1.14e-05	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—UCP3—prostate cancer	1.14e-05	0.000127	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—ITGB3—prostate cancer	1.12e-05	0.000124	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD3B1—prostate cancer	1.09e-05	0.000121	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC22A3—prostate cancer	1.09e-05	0.000121	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PTEN—prostate cancer	1.08e-05	0.00012	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.06e-05	0.000117	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	1.05e-05	0.000116	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA4—prostate cancer	1.04e-05	0.000116	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TBXAS1—prostate cancer	1.04e-05	0.000116	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—EP300—prostate cancer	1.03e-05	0.000115	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.02e-05	0.000113	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.02e-05	0.000113	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA2—prostate cancer	1.02e-05	0.000113	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SULT1A1—prostate cancer	1.01e-05	0.000111	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ABCG5—prostate cancer	1.01e-05	0.000111	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PLAU—prostate cancer	9.87e-06	0.000109	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTA1—prostate cancer	9.82e-06	0.000109	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NAT2—prostate cancer	9.71e-06	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTO1—prostate cancer	9.71e-06	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HSD3B2—prostate cancer	9.71e-06	0.000108	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CAV1—prostate cancer	9.64e-06	0.000107	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	9.35e-06	0.000104	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.34e-06	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LRP2—prostate cancer	9.31e-06	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PLCB2—prostate cancer	9.31e-06	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2C18—prostate cancer	9.31e-06	0.000103	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—P4HB—prostate cancer	9.13e-06	0.000101	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC22A1—prostate cancer	8.88e-06	9.84e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	8.88e-06	9.84e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CG—prostate cancer	8.78e-06	9.73e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.78e-06	9.73e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EGF—prostate cancer	8.68e-06	9.62e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SULT2A1—prostate cancer	8.66e-06	9.59e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MED12—prostate cancer	8.52e-06	9.44e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GNG5—prostate cancer	8.45e-06	9.36e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—CREBBP—prostate cancer	8.14e-06	9.02e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA3—prostate cancer	8.14e-06	9.02e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IGF1—prostate cancer	8.04e-06	8.91e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8e-06	8.86e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	7.96e-06	8.82e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—HPGDS—prostate cancer	7.76e-06	8.6e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CD—prostate cancer	7.72e-06	8.56e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2C19—prostate cancer	7.71e-06	8.55e-05	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—PIK3CA—prostate cancer	7.65e-06	8.48e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SERPINE1—prostate cancer	7.64e-06	8.46e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTT1—prostate cancer	7.53e-06	8.34e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ACHE—prostate cancer	7.53e-06	8.34e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2A6—prostate cancer	7.44e-06	8.25e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.41e-06	8.22e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—NOS3—prostate cancer	7.29e-06	8.08e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKR1C3—prostate cancer	7.24e-06	8.02e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PRKACB—prostate cancer	7.2e-06	7.98e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP17A1—prostate cancer	7.13e-06	7.9e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—JAK2—prostate cancer	7.09e-06	7.85e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.05e-06	7.81e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.03e-06	7.79e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA2—prostate cancer	6.79e-06	7.53e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CB—prostate cancer	6.73e-06	7.46e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.5e-06	7.21e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—SLC5A5—prostate cancer	6.48e-06	7.18e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP2E1—prostate cancer	6.33e-06	7.01e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NQO1—prostate cancer	6.26e-06	6.93e-05	CbGpPWpGaD
Ethacrynic acid—GSTA2—Metabolism—AKT1—prostate cancer	6.25e-06	6.93e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—IL2—prostate cancer	6.18e-06	6.85e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TH—prostate cancer	6.17e-06	6.83e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.13e-06	6.79e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP3A4—prostate cancer	6.1e-06	6.76e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.07e-06	6.73e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1B1—prostate cancer	6e-06	6.65e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GGT1—prostate cancer	5.81e-06	6.44e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NCOA1—prostate cancer	5.72e-06	6.34e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP19A1—prostate cancer	5.64e-06	6.25e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—EP300—prostate cancer	5.55e-06	6.15e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—RXRA—prostate cancer	5.44e-06	6.03e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—SRC—prostate cancer	5.39e-06	5.98e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.3e-06	5.87e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—VEGFA—prostate cancer	5.25e-06	5.82e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—COMT—prostate cancer	5.24e-06	5.81e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTP1—prostate cancer	5.22e-06	5.78e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ITPR1—prostate cancer	5.14e-06	5.69e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.05e-06	5.6e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—TYMS—prostate cancer	4.85e-06	5.38e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TGFB1—prostate cancer	4.82e-06	5.34e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—GSTM1—prostate cancer	4.8e-06	5.32e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—LPL—prostate cancer	4.71e-06	5.22e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CYP1A1—prostate cancer	4.55e-06	5.04e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—ERCC2—prostate cancer	4.51e-06	5e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—KRAS—prostate cancer	4.47e-06	4.95e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—MTHFR—prostate cancer	4.24e-06	4.7e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PPARA—prostate cancer	4.16e-06	4.61e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—PIK3CA—prostate cancer	4.1e-06	4.55e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—TP53—prostate cancer	3.97e-06	4.4e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CAV1—prostate cancer	3.91e-06	4.33e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.74e-06	4.14e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CG—prostate cancer	3.56e-06	3.95e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—INS—prostate cancer	3.37e-06	3.74e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Hemostasis—AKT1—prostate cancer	3.35e-06	3.71e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—CREBBP—prostate cancer	3.3e-06	3.66e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CD—prostate cancer	3.13e-06	3.47e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—NOS3—prostate cancer	2.96e-06	3.28e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CB—prostate cancer	2.73e-06	3.02e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTGS2—prostate cancer	2.7e-06	3e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PTEN—prostate cancer	2.36e-06	2.61e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—EP300—prostate cancer	2.25e-06	2.49e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—PIK3CA—prostate cancer	1.66e-06	1.84e-05	CbGpPWpGaD
Ethacrynic acid—ALB—Metabolism—AKT1—prostate cancer	1.36e-06	1.51e-05	CbGpPWpGaD
